Cholesterol determines the cytosolic entry and seeded aggregation of tau BJ Tuck, LVC Miller, T Katsinelos, AE Smith, EL Wilson, S Keeling, ... Cell Reports 39 (5), 2022 | 35 | 2022 |
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models AS Mukadam, LVC Miller, AE Smith, M Vaysburd, SA Sakya, S Sanford, ... Science 379 (6639), 1336-1341, 2023 | 31 | 2023 |
Tau assemblies do not behave like independently acting prion-like particles in mouse neural tissue LVC Miller, AS Mukadam, CS Durrant, MJ Vaysburd, T Katsinelos, ... Acta neuropathologica communications 9 (1), 1-16, 2021 | 20 | 2021 |
The type‐I interferon response potentiates seeded tau aggregation and exacerbates tau pathology SAI Sanford, LVC Miller, M Vaysburd, S Keeling, BJ Tuck, J Clark, ... Alzheimer's & Dementia, 2023 | 11 | 2023 |
Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function LVC Miller, G Papa, M Vaysburd, S Cheng, PW Sweeney, A Smith, ... Cell, 2024 | | 2024 |
Aggregate-selective removal of pathological tau by clustering-activated degraders J Benn, S Cheng, S Keeling, AE Smith, MJ Vaysburd, D Böken, LVC Miller, ... Science 385 (6712), 1009-1016, 2024 | | 2024 |